Celgene Corporation Rallies Following JP Morgan Upgrade

By: via Benzinga
Celgene Corporation (NASDAQ: CELG) is 'Too cheap to ignore'. Upgraded from Neutral to Overweight with price target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.